Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS

Transformational crossing system to prevent amputation and treat complex chronic total occlusions in critical limb ischemia

Objetivo

Critical limb Threatening ischemia (CLTI) is caused by chronic total occlusions (CTOs) in the arteries of the lower extremities. Left untreated, the complications of CLTI results in amputation of the affected limb. The prognosis for those diagnosed with CLTI is comparative to an aggressive cancer. At 1 year post diagnosis, 25% of patients will die and 30% had an amputation, 60% are dead by year 5

CTO is caused by the build-up and calcification of plaque inside the artery, blocking the artery and hardens over time and prevents the passage of a guidewire or therapy device through the vessel. Versono has designed and developed a solution to allow an endovascular surgeon to confidently cross 90% of occlusions within 10 mins

This dedicated CTO guidewire uses an acoustic wave (ultrasound) to penetrate through the calcium/plaque and enable physicians to apply other treatments like stents, balloons or atherectomy devices to unblock the CTO and restore blood flow to the tissue downstream.

Ámbito científico (EuroSciVoc)

Palabras clave

Programa(s)

Tema(s)

Régimen de financiación

HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended Finance

Ver todos los proyectos financiados en el marco de este régimen de financiación

Convocatoria de propuestas

(se abrirá en una nueva ventana) HORIZON-EIC-2023-ACCELERATOR-01

Ver todos los proyectos financiados en el marco de esta convocatoria

Coordinador

VERSONO MEDICAL LIMITED
Aportación neta de la UEn
€ 2 478 175,00
Dirección
PARKMORE WEST BUSINESS PARK
H91 HP4F Galway
Irlanda
Pyme
Sí
Región
Ireland Northern and Western West
Tipo de actividad
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Enlaces
Coste total
€ 3 544 625,00